|
Coagulation inhibitors
Contributing journals to this collection:
Hypertension,
Circulation: Heart Failure,
Stroke,
Circulation Research,
Circulation: Arrhythmia and Electrophysiology,
Circulation: Cardiovascular Genetics,
Arteriosclerosis, Thrombosis, and Vascular Biology,
Circulation: Cardiovascular Outcomes and Quality,
Circulation,
Circulation: Cardiovascular Interventions,
and Circulation: Cardiovascular Imaging
Citations 1-10 of 105 total displayed.
- Articles
Stent-Assisted Coiling of Intracranial Aneurysms. Clinical and Angiographic Results in 216 Consecutive Aneurysms
- Michel Piotin, Raphaël Blanc, Laurent Spelle, Charbel Mounayer, Rhelen Piantino, Paul J. Schmidt, and Jacques Moret
Stroke published December 3, 2009, doi:10.1161/STROKEAHA.109.558114
[Abstract]
- Interventional Cardiology
Intensifying Platelet Inhibition With Tirofiban in Poor Responders to Aspirin, Clopidogrel, or Both Agents Undergoing Elective Coronary Intervention: Results From the Double-Blind, Prospective, Randomized Tailoring Treatment With Tirofiban in Patients Showing Resistance to Aspirin and/or Resistance to Clopidogrel Study
- Marco Valgimigli, Gianluca Campo, Nicoletta de Cesare, Emanuele Meliga, Pascal Vranckx, Alessandro Furgieri, Dominick J. Angiolillo, Manel Sabatè, Martial Hamon, Alessandra Repetto, Salvatore Colangelo, Salvatore Brugaletta, Giovanni Parrinello, Gianfranco Percoco, Roberto Ferrari for the Tailoring Treatment With Tirofiban in Patients Showing Resistance to Aspirin and/or Resistance to Clopidogrel (3T/2R) Investigators
Circulation 2009;119:3215-3222; published online before print as doi:10.1161/CIRCULATIONAHA.108.833236
[Abstract]
[Full text]
- Articles
Intensifying Platelet Inhibition With Tirofiban in Poor Responders to Aspirin, Clopidogrel, or Both Agents Undergoing Elective Coronary Intervention. Results From the Double-Blind, Prospective, Randomized Tailoring Treatment With Tirofiban in Patients Showing Resistance to Aspirin and/or Resistance to Clopidogrel Study
- Marco Valgimigli, Gianluca Campo, Nicoletta de Cesare, Emanuele Meliga, Pascal Vranckx, Alessandro Furgieri, Dominick J. Angiolillo, Manel Sabatè, Martial Hamon, Alessandra Repetto, Salvatore Colangelo, Salvatore Brugaletta, Giovanni Parrinello, Gianfranco Percoco, Roberto Ferrari for the Tailoring Treatment With Tirofiban in Patients Showing Resistance to Aspirin and/or Resistance to Clopidogrel (3T/2R) Investigators
Circulation published June 15, 2009, doi:10.1161/CIRCULATIONAHA.108.833236
[Abstract]
- Editorials
What to Do With Patients Receiving Long-Term Clopidogrel: Reload or Relax?
- David O. Williams and J. Dawn Abbott
Circulation 2008;118:1219-1222, doi:10.1161/CIRCULATIONAHA.108.804229
[Full text]
- Coronary Heart Disease
Phase 1b Randomized Study of Antidote-Controlled Modulation of Factor IXa Activity in Patients With Stable Coronary Artery Disease
- Mark Y. Chan, Mauricio G. Cohen, Christopher K. Dyke, Shelley K. Myles, Laura G. Aberle, Min Lin, James Walder, Steven R. Steinhubl, Ian C. Gilchrist, Neal S. Kleiman, David A. Vorchheimer, Nicholas Chronos, Chiara Melloni, John H. Alexander, Robert A. Harrington, Ross M. Tonkens, Richard C. Becker, and Christopher P. Rusconi
Circulation 2008;117:2865-2874; published online before print as doi:10.1161/CIRCULATIONAHA.107.745687
[Abstract]
[Full text]
- Articles
Phase 1b Randomized Study of Antidote-Controlled Modulation of Factor IXa Activity in Patients With Stable Coronary Artery Disease
- Mark Y. Chan, Mauricio G. Cohen, Christopher K. Dyke, Shelley K. Myles, Laura G. Aberle, Min Lin, James Walder, Steven R. Steinhubl, Ian C. Gilchrist, Neal S. Kleiman, David A. Vorchheimer, Nicholas Chronos, Chiara Melloni, John H. Alexander, Robert A. Harrington, Ross M. Tonkens, Richard C. Becker, and Christopher P. Rusconi
Circulation published May 27, 2008, doi:10.1161/CIRCULATIONAHA.107.745687
[Abstract]
- Coronary Heart Disease
Prasugrel Compared With High Loading- and Maintenance-Dose Clopidogrel in Patients With Planned Percutaneous Coronary Intervention: The Prasugrel in Comparison to Clopidogrel for Inhibition of Platelet Activation and Aggregation–Thrombolysis in Myocardial Infarction 44 Trial
- Stephen D. Wiviott, Dietmar Trenk, Andrew L. Frelinger, Michelle O’Donoghue, Franz-Josef Neumann, Alan D. Michelson, Dominick J. Angiolillo, Hanoch Hod, Gilles Montalescot, Debra L. Miller, Joseph A. Jakubowski, Richard Cairns, Sabina A. Murphy, Carolyn H. McCabe, Elliott M. Antman, Eugene Braunwald for the PRINCIPLE-TIMI 44 Investigators
Circulation 2007;116:2923-2932; published online before print as doi:10.1161/CIRCULATIONAHA.107.740324
[Abstract]
[Full text]
- Articles
Prasugrel Compared With High Loading- and Maintenance-Dose Clopidogrel in Patients With Planned Percutaneous Coronary Intervention. The Prasugrel in Comparison to Clopidogrel for Inhibition of Platelet Activation and Aggregation–Thrombolysis in Myocardial Infarction 44 Trial
- Stephen D. Wiviott, Dietmar Trenk, Andrew L. Frelinger, Michelle O'Donoghue, Franz-Josef Neumann, Alan D. Michelson, Dominick J. Angiolillo, Hanoch Hod, Gilles Montalescot, Debra L. Miller, Joseph A. Jakubowski, Richard Cairns, Sabina A. Murphy, Carolyn H. McCabe, Elliott M. Antman, Eugene Braunwald for the PRINCIPLE-TIMI 44 Investigators
Circulation published December 3, 2007, doi:10.1161/CIRCULATIONAHA.107.740324
[Abstract]
- Thrombosis
Effects of Unfractionated Heparin and Glycoprotein IIb/IIIa Antagonists Versus Bivalirdin on Myeloperoxidase Release From Neutrophils
- Guohong Li, Alison C. Keenan, Justin C. Young, Margaret J. Hall, Zehra Pamuklar, E. Magnus Ohman, Steven R. Steinhubl, and Susan S. Smyth
Arterioscler Thromb Vasc Biol 2007;27:1850-1856; published online before print as doi:10.1161/ATVBAHA.107.144576
[Abstract]
[Full text]
- Editorials
A Replacement for Warfarin: The Search Continues
- John W. Eikelboom and Jeffrey I. Weitz
Circulation 2007;116:131-133; published online before print as doi:10.1161/CIRCULATIONAHA.107.712349
[Full text]
|
|
